Carmustine, BCNU implant wafers
What is this medicine?
CARMUSTINE, BCNU (kar MUS teen) is a chemotherapy drug. It interferes with the growth of rapidly growing cells like cancer cells. This medicine is used to treat glioma and glioblastoma. The wafers are placed at a site where a brain tumor used to be, at the end of a surgery to remove the tumor.
How should I use this medicine?
This drug is placed into the space made when a tumor is removed. It is administered during surgery in a hospital.
Talk to your pediatrician regarding the use of this medicine in children. Special care may be needed.
What side effects may I notice from receiving this medicine?
Side effects that you should report to your doctor or health care professional as soon as possible:
allergic reactions like skin rash, itching or hives, swelling of the face, lips, or tongue
changes in vision
stiff neck and sensitivity to light
Side effects that usually do not require medical attention (report to your doctor or health care professional if they continue or are bothersome):
changes in emotions or moods
What may interact with this medicine?
Interactions are not expected.
What if I miss a dose?
This does not apply.
Where should I keep my medicine?
This drug is given in a hospital and will not be stored at home.
What should I tell my health care provider before I take this medicine?
They need to know if you have any of these conditions:
an unusual or allergic reaction to carmustine, BCNU, other medicines, foods, dyes, or preservatives
pregnant or trying to get pregnant
What should I watch for while using this medicine?
Visit your doctor for checks on your progress. You will need to have regular blood work. Report any side effects.
This may interfere with the ability to father a child. You should talk to your doctor or health care professional if you are concerned about your fertility.
Do not become pregnant while taking this medicine. Women should inform their doctor if they wish to become pregnant or think they might be pregnant. There is a potential for serious side effects to an unborn child. Talk to your health care professional or pharmacist for more information. Do not breast-feed an infant while taking this medicine.
Online Medical Reviewer:
Date Last Reviewed: Unavailable
NOTE:This sheet is a summary. It may not cover all possible information. If you have questions about this medicine, talk to your doctor, pharmacist, or health care provider. Copyright© 2019 Elsevier
- Astrocytoma in Children
- Brain Tumors in Children
- Hodgkin Lymphoma in Children
- Neck Masses
- Non-Hodgkin Lymphoma in Children
- Arsenic Trioxide injection
- Bleomycin injection
- Bortezomib injection
- Carmustine, BCNU injection
- Chlorambucil tablets
- Cladribine injection for infusion
- Cyclophosphamide injection
- Cyclophosphamide tablets or Capsules
- Dacarbazine, DTIC injection
- Denileukin Diftitox injection
- Doxorubicin injection
- Fludarabine injection
- Fludarabine tablets
- Ifosfamide injection
- Interferon Alfa-2b injection
- Lomustine, CCNU capsules
- Mechlorethamine, Nitrogen Mustard injection
- Mechlorethamine topical gel
- Melphalan injection
- Melphalan tablets
- Methotrexate injection
- Methotrexate subcutaneous injection
- Methotrexate tablets
- Mitoxantrone injection
- Nelarabine solution for injection
- Plerixafor injection
- Procarbazine capsules
- Rituximab injection
- Temozolomide capsules
- Temozolomide injection
- Tositumomab (Murine) Solution for injection, Tositumomab (Murine) Solution for injection
- Vinblastine injection
- Vincristine injection
- Zoledronic Acid injection (Hypercalcemia, Oncology)
- Zoledronic Acid injection (Paget's Disease, Osteoporosis)